MEASUREMENT OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND DERIVATIVES CONTAINING THE U-PA SERINE PROTEASE DOMAIN

被引：0
|
作者：
VANKEER, L [1 ]
DECLERCK, PJ [1 ]
VERSTREKEN, M [1 ]
COLLEN, D [1 ]
机构：
[1] CATHOLIC UNIV LEUVEN,CTR THROMBOSIS & VASC RES,B-3000 LOUVAIN,BELGIUM
来源：
THROMBOSIS AND HAEMOSTASIS | 1991年 / 65卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1268 / 1268
页数：1
相关论文
共 50 条
  • [21] Expression of urokinase type plasminogen activator (u-PA) and U-PA inhibitor (PAI-1) in lung cancers: Clinical significance
    Brambilla, E
    Robert, C
    Bolon, I
    Decaussin, M
    LABORATORY INVESTIGATION, 1999, 79 (01) : 181A - 181A
  • [22] THROMBOLYTIC AND PHARMACOKINETIC PROPERTIES OF AN IMMUNOCONJUGATE OF SINGLE-CHAIN UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND A BISPECIFIC MONOCLONAL-ANTIBODY AGAINST FIBRIN AND AGAINST U-PA IN BABOONS
    IMURA, Y
    STASSEN, JM
    KUROKAWA, T
    IWASA, S
    LIJNEN, HR
    COLLEN, D
    BLOOD, 1992, 79 (09) : 2322 - 2329
  • [23] HEPATOCYTE GROWTH-FACTOR INCREASES UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND U-PA RECEPTOR EXPRESSION IN MADIN-DARBY CANINE KIDNEY EPITHELIAL-CELLS
    PEPPER, MS
    MATSUMOTO, K
    NAKAMURA, T
    ORCI, L
    MONTESANO, R
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (28) : 20493 - 20496
  • [24] DOMAIN ANALYSIS OF UROKINASE PLASMINOGEN-ACTIVATOR (U-PA) - PREPARATION AND CHARACTERIZATION OF INTACT A-CHAIN MOLECULES
    MAZAR, AP
    BUKO, A
    PETROS, AM
    BARNATHAN, ES
    HENKIN, J
    FIBRINOLYSIS, 1992, 6 : 49 - 55
  • [25] PROGESTERONE STIMULATES DEGRADATION OF UROKINASE PLASMINOGEN-ACTIVATOR (U-PA) IN ENDOMETRIAL STROMAL CELLS BY INCREASING ITS INHIBITOR AND SURFACE EXPRESSION OF THE U-PA RECEPTOR
    CASSLEN, B
    NORDENGREN, J
    GUSTAVSSON, B
    NILBERT, M
    LUND, LR
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (09): : 2776 - 2784
  • [26] ABSENT UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) RELEASE UPON DDAVP IN PATIENTS WITH DEEP-VEIN THROMBOSIS
    LEVI, M
    LENSING, A
    PRANDONI, P
    DOOIJEWAAARD, G
    CANOVA, B
    BULLER, HR
    CUPPINI, S
    TENCATE, JW
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 392 - 392
  • [27] A BISPECIFIC MONOCLONAL-ANTIBODY AGAINST HUMAN FIBRIN AND AGAINST UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) ENHANCES CLOT LYSIS BY U-PA IN ANIMAL-MODELS OF VENOUS THROMBOSIS
    STASSEN, JM
    KUROKAWA, T
    IWASA, S
    KAKINUMA, A
    LIJNEN, HR
    COLLEN, D
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 788 - 788
  • [28] THE ROLE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND PALSMINOGEN ACTIVATOR INHIBITOR-2 (PAI-2) IN KERATINOCYTE PROLIFERATION
    HIBINO, T
    OONUMA, M
    TAKAHASHI, T
    HORII, I
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (04) : 633 - 633
  • [29] PLASMA-CONCENTRATIONS OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (U-PA) AND ITS RECEPTOR (U-PAR) IN LIVER AND PROSTATE-CANCER
    PARAMO, JA
    HERRERO, I
    ROBLES, JE
    HERMIDA, J
    RIFON, J
    ROCHA, E
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1290 - 1290
  • [30] INVITRO STUDIES ON THE BINDING OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (T-PA) AND UROKINASE (U-PA) TO LIVER MEMBRANES
    KALYAN, NK
    LEE, SG
    HUM, WT
    HARTZELL, R
    LEVNER, M
    HUNG, PP
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 217 - 217
12345